About Alexza
Alexza is a company based in Mountain View (United States) founded in 2000. Alexza has raised $97 million across 8 funding rounds from investors including T. Rowe Price, Frazier Healthcare Partners and Abingworth. Alexza offers products and services including Staccato Technology and Adasuve. Alexza operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, MannKind Corp, Neurocrine and PTC Therapeutics, among others.
- Total Equity Funding$97M (USD)
in 8 rounds
- Latest Funding Round$5M (USD), Post-IPO
Feb 2016
- InvestorsT. Rowe Price
& 13 more
Products & Services of Alexza
Alexza offers a comprehensive portfolio of products and services, including Staccato Technology and Adasuve.
Handheld inhaler for rapid systemic drug delivery to treat medical conditions.
Treatment for agitation in schizophrenia or bipolar disorder via inhalation.
Apps and channels of Alexza
its YouTube channel Ferrer has 98 subscribers and 30 videos.
Videos from Alexza
The most watched videos on Alexza's YouTube channel, Ferrer (98 subscribers). Click a video to play it here.
More on Ferrer.
Funding Insights of Alexza
Alexza has successfully raised a total of $97M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97M
- Total Rounds 8
- Last Round Post-IPO — $5M
- First Round $45M
(Sep 2002)
- Investors Count 14
All 8 funding rounds of Alexza with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $5M | Post-IPO | – | – | – |
| Sep 2015 | $143,750 | Post-IPO | – | – | – |
| Oct 2014 | $8M | Post-IPO | – | – | – |
| Mar 2012 | $3M | Post-IPO | – | – | – |
| May 2010 | $1.01M | Post-IPO | – | – | – |
| Oct 2009 | $19.72M | Post-IPO | – | – | – |
| Jan 2005 | $52M | Series D | – | Alloy Ventures, Delphi Ventures | |
| Sep 2002 | $45M | Series C | – | Frazier Healthcare Partners, Versant Ventures |
14 investors in total: 13 institutional and 1 angel.
Investors in Alexza
Alexza has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include T. Rowe Price, Frazier Healthcare Partners and Abingworth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage venture capital firm investing in the US | – | alloyventures.com | Palo Alto, United States | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
- | – | mdscapital.com | - | |
Pacific Rim Ventures is involved in unspecified business activities. | – | pacificrimventures.com | - | |
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Venture capital fund backed incubator focused on the healthcare startups | – | 5amventures.com | San Francisco, United States | |
Venture capital investments are offered to startups by NEA. | – | nea.com | Menlo Park, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States |
Investor details for Alexza
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Alexza
4 dated milestones of Alexza across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Alexza is founded.
- Funding First funding round of $45.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $5.0M.
Competitors of Alexza
Alexza operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, MannKind Corp, Neurocrine and PTC Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| mannkindcorp.com | 1991 | Los Angeles, United States | $50M | 322 | Developer of small-molecule drugs | |
| neurocrine.com | 1992 | San Diego, United States | $10M | 1,400 | Developer of small molecule therapeutics for endocrine and CNS disorders | |
| ptcbio.com | 1998 | South Plainfield, United States | $248.1M | 995 | Small molecule drugs for rare diseases are developed. | |
| biohavenpharma.com | 2014 | New Haven, United States | $84.1M | 932 | Therapies for neurological and neuropsychiatric diseases are developed. | |
| askbio.com | 2001 | Durham, United States | $235M | – | Gene and protein therapies are developed for treating various diseases. | |
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| karunatx.com | 2009 | Boston, United States | $132.1M | 339 | Therapies for psychosis and cognitive impairment are developed. |
Detailed competitors of Alexza
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alexza
Websites that share an audience with Alexza (alexza.com).
Websites whose visitors overlap most with Alexza. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| afnm.com | 100% | – | – | View details | |
| astx.com | 99% | 8.9K | #2,592,392 | View details | |
| conatuspharma.com | 98% | 1K | #14,248,892 | View details | |
| delmarpharma.com | 98% | 3.6K | #5,760,147 | View details | |
| mvpharm.com | 98% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Alexza
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Alexza
Complete news archive for Alexza
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Alexza
10 companies that operate in the same segment as Alexza (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alexza
Alexza was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Alexza is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Alexza is a funded company, having raised a total of $97M across 8 funding rounds to date. The company's 1st funding round was a Series C of $45M, raised on Sep 2002.
Founded in 2000, Alexza is engaged in the biotechnology sector, focusing on the development of inhalation-based therapeutics for acute and intermittent conditions. Proprietary Staccato system technology is utilized to vaporize drug compounds for delivery through deep lung inhalation. Key products include treatments for migraine, panic attacks, breakthrough pain, and acute agitation in schizophrenia patients. Operations are based in Mountain View, United States.
Alexza's top competitors include Jazz Pharmaceuticals, MannKind Corp and PTC Therapeutics.
Alexza offers Staccato Technology and Adasuve.
Alexza has 14 investors. Key investors include T. Rowe Price, Frazier Healthcare Partners, Abingworth, Burrill and Company, and Alloy Ventures.
Alexza operates through Alexza Pharmaceuticals.